The effects of nucleoside analogs on cutaneous neoplasms.
D015092:3-Deazauridine / Q000627:therapeutic use*; D000241:Adenosine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D002280:Basal Cell Carcinoma / Q000188:drug therapy*; D006801:Humans; D008297:Male; D012263:Ribonucleosides / Q000627:therapeutic use*; D012878:Skin Neoplasms / Q000188:drug therapy*; D013449:Sulfonamides / Q000627:therapeutic use; D014372:Tubercidin / Q000627:therapeutic use*; D014529:Uridine / Q000031:analogs & derivatives*
D012263:Ribonucleosides; D013449:Sulfonamides; D015092:3-Deazauridine; D000241:Adenosine; D014372:Tubercidin; D014529:Uridine